tiprankstipranks
Trending News
More News >
Alexandria Real Estate Equities (ARE)
NYSE:ARE
Advertisement

Alexandria Equities (ARE) AI Stock Analysis

Compare
1,058 Followers

Top Page

ARE

Alexandria Equities

(NYSE:ARE)

Rating:60Neutral
Price Target:
$80.00
▼(-5.55% Downside)
The overall stock score of 60 reflects a balanced view of Alexandria Equities. Strong revenue growth and efficient cash flow management are positive indicators, but the net loss and negative ROE are significant concerns. The earnings call provided a balanced outlook with notable achievements and challenges. Technical indicators suggest mixed momentum, and the valuation is hindered by a negative P/E ratio, though the high dividend yield offers some appeal.
Positive Factors
Financial Performance
Investment income came in strong, with ARE realizing ~$32.1m of investment gains during the quarter, above estimates.
Leasing Activity
ARE executed on 1.3m sq.ft. of leasing activity during the quarter, which is above historical averages, a positive given high supply in the market.
Stock Valuation
ARE is trading at an approximately 30% discount to NAV, offering a potential total return of around 39% including capital appreciation and yield.
Negative Factors
Job Market
Life science job listings in ARE's markets continued to decline, with job listings soft relative to the 'go-go' years of 2020-2022, and below the average of '18-'19.
Market Conditions
New supply continues to be an overhang, with high vacancy rates in the nation's two largest lab markets, the Bay Area and Boston.
Supply and Demand
Supply/demand imbalance remains a concern for the asset class, which limits the growth outlook through '26 due to occupancy headwinds, narrowing re-leasing spreads, and minimal accretion from development.

Alexandria Equities (ARE) vs. SPDR S&P 500 ETF (SPY)

Alexandria Equities Business Overview & Revenue Model

Company DescriptionAlexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office real estate investment trust (REIT), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $31.9 billion as of December 31, 2020, and an asset base in North America of 49.7 million square feet (SF). The asset base in North America includes 31.9 million RSF of operating properties and 3.3 million RSF of Class A properties undergoing construction, 7.1 million RSF of near-term and intermediate-term development and redevelopment projects, and 7.4 million SF of future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, technology, and agtech campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, technology, and agtech companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
How the Company Makes MoneyAlexandria Equities generates revenue primarily through leasing its properties to tenants in the life sciences and technology sectors. The company's revenue model is based on long-term leases, which provide a stable income stream. Key revenue streams include rental income from both traditional office spaces and specialized lab facilities. Alexandria also engages in development projects, enhancing its portfolio's value and generating additional income through the eventual leasing of these newly developed spaces. Significant partnerships with universities and research institutions further contribute to its earnings by securing long-term tenants and fostering collaborative environments that attract additional clients.

Alexandria Equities Earnings Call Summary

Earnings Call Date:Jul 21, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 27, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted significant achievements such as the largest lease in company history and international recognition, indicating resilience and successful execution in key areas. However, challenges were evident in occupancy declines, public biotech market struggles, and asset impairments, creating a balanced outlook.
Q2-2025 Updates
Positive Updates
Largest Lease in Company History
Alexandria secured a 466,000 square foot lease, the largest in the company's history, demonstrating resilience and long-term commitment with a high credit tenant.
Significant Progress in Asset Sales
The company completed $1.1 billion in sales in the fourth quarter of 2024 and has about $1.1 billion more to add to their executable sales pipeline for the next two quarters.
International Building of the Year Award
Alexandria won its first international Building of the Year Award for 8 Davis Drive, a 150,000 square foot R&D building, showcasing operational excellence.
Strong Venture Funding in Life Sciences
Life Science venture funding remained steady with nearly $22 billion deployed in the first half of the year, highlighting resilience in the industry.
High Quality Tenant Base
75% of annual rental revenue comes from the highly distinguished Megacampus platform, with 53% of annual rental revenue from investment-grade or publicly traded large cap tenants.
Negative Updates
Occupancy Decline
Occupancy at the end of the quarter was 90.8%, down 90 basis points from the prior quarter, reflecting challenges in maintaining leasing momentum.
Challenges in Public Biotech Markets
The public biotech equity market remains tough with no biotech IPOs in the second quarter, and the risk-off environment is affecting leasing decisions.
Same Property NOI Decline
Same property NOI was down 5.4% for the quarter due to recent declines in occupancy and the burn-off of initial free rent from last year.
Increased Free Rent Concessions
Free rent was elevated during the quarter, which, though it helped secure long-term leases, indicates challenges in tenant acquisition.
Asset Impairments
Recognized impairments of real estate of $129.6 million during the quarter, impacting financial performance.
Company Guidance
During the second quarter of 2025, Alexandria Real Estate Equities reported solid performance amidst macroeconomic challenges, highlighting several key metrics and strategic initiatives. The company executed the largest lease in its history, a 466,000 square foot build-to-suit, which underscores the trust and value of Alexandria's brand. The quarter's occupancy stood at 90.8%, with a year-end target between 90.9% and 92.5%. Same-property NOI decreased by 5.4%, while cash-based NOI increased by 2%. The company completed approximately 770,000 square feet of leasing, with tenant improvements and leasing commissions on renewals down 40% from previous quarters. Alexandria plans to add $1.1 billion to its sales pipeline over the next two quarters, having already completed $1.1 billion in sales in Q4 2024. Additionally, Alexandria reported $60 million in gains from venture investments for the first half of 2025. The company maintains a robust balance sheet with corporate credit ratings in the top 10% of all publicly traded U.S. REITs and liquidity of $4.6 billion, aiming to achieve a year-end leverage target of 5.2x net debt to adjusted EBITDA.

Alexandria Equities Financial Statement Overview

Summary
Alexandria Equities shows strong revenue growth and efficient cash flow management. However, the recent net loss and negative return on equity are significant concerns impacting long-term profitability and shareholder value.
Income Statement
65
Positive
Alexandria Equities shows a strong revenue growth rate of 22.6% TTM, indicating robust top-line expansion. However, the net profit margin has turned negative TTM, primarily due to a net loss, which raises concerns about profitability. The gross profit margin remains healthy at approximately 69.6%, and the EBIT margin is stable at 17.3%, suggesting operational efficiency despite the net loss.
Balance Sheet
58
Neutral
The company's debt-to-equity ratio is relatively low at 0.71, indicating moderate leverage. However, the return on equity has turned negative TTM, reflecting the net loss and impacting shareholder returns. The equity ratio is stable, suggesting a solid capital structure, but the negative ROE is a concern.
Cash Flow
70
Positive
Operating cash flow remains strong with a high coverage ratio of 6.18 TTM, indicating good cash generation relative to net income. Free cash flow growth is positive at 3.53% TTM, showing improvement. The free cash flow to net income ratio is 1.0, highlighting efficient cash conversion despite the net loss.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.04B3.05B2.84B2.59B2.11B1.89B
Gross Profit2.12B2.14B1.98B1.81B1.49B1.36B
EBITDA1.84B1.90B1.45B1.63B1.35B1.23B
Net Income-12.85M322.95M103.64M521.66M416.83M591.20M
Balance Sheet
Total Assets37.62B37.53B36.77B35.52B30.22B22.83B
Cash, Cash Equivalents and Short-Term Investments520.54M552.15M618.19M825.19M361.35M568.53M
Total Debt13.66B12.75B11.70B10.57B9.23B7.91B
Total Liabilities15.88B15.13B14.15B12.84B11.19B9.38B
Stockholders Equity17.18B17.89B18.47B18.97B16.19B11.73B
Cash Flow
Free Cash Flow1.42B1.50B1.63B1.29B-6.32B-2.39B
Operating Cash Flow1.42B1.50B1.63B1.29B1.01B882.51M
Investing Cash Flow-1.03B-1.51B-2.50B-5.08B-7.11B-3.28B
Financing Cash Flow-425.32M-93.31M674.16M4.23B5.92B2.75B

Alexandria Equities Technical Analysis

Technical Analysis Sentiment
Positive
Last Price84.70
Price Trends
50DMA
77.94
Positive
100DMA
74.79
Positive
200DMA
84.87
Negative
Market Momentum
MACD
1.75
Negative
RSI
67.94
Neutral
STOCH
88.35
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ARE, the sentiment is Positive. The current price of 84.7 is above the 20-day moving average (MA) of 78.70, above the 50-day MA of 77.94, and below the 200-day MA of 84.87, indicating a neutral trend. The MACD of 1.75 indicates Negative momentum. The RSI at 67.94 is Neutral, neither overbought nor oversold. The STOCH value of 88.35 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ARE.

Alexandria Equities Risk Analysis

Alexandria Equities disclosed 11 risk factors in its most recent earnings report. Alexandria Equities reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Alexandria Equities Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$6.92B24.149.67%3.91%2.95%
74
Outperform
$4.95B22.474.06%5.06%2.26%10.15%
69
Neutral
$4.95B79.821.30%4.34%13.07%-4.94%
65
Neutral
$8.62B10.2214.93%1.79%1.38%4370.96%
63
Neutral
$7.09B13.59-0.50%6.85%4.08%-25.24%
62
Neutral
$13.11B3,802.530.07%5.10%3.24%-97.73%
60
Neutral
$14.65B102.63-0.12%6.21%3.12%-116.29%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ARE
Alexandria Equities
84.70
-27.06
-24.21%
BXP
Boston Properties
76.83
6.47
9.20%
CUZ
Cousins Properties
29.47
2.28
8.39%
KRC
Kilroy Realty
42.70
10.15
31.18%
VNO
Vornado Realty
41.29
8.49
25.88%
CDP
COPT Defense Properties
30.66
2.65
9.46%

Alexandria Equities Corporate Events

Executive/Board ChangesShareholder Meetings
Alexandria Equities Approves Key Proposals at Annual Meeting
Neutral
May 15, 2025

On May 13, 2025, Alexandria Real Estate Equities, Inc. held its 2025 Annual Meeting of Stockholders, where several key proposals were approved, including the amendment and restatement of the Amended 1997 Incentive Plan. This amendment increases the number of shares available for grant, specifies the treatment of performance-based awards in the event of a change of control, and clarifies the prohibition of granting stock options and stock appreciation rights. Additionally, the meeting saw the election of eight directors, approval of executive compensation, ratification of Ernst & Young LLP as auditors, and the approval of a stockholder proposal titled ‘Simple Majority Vote’.

The most recent analyst rating on (ARE) stock is a Hold with a $117.00 price target. To see the full list of analyst forecasts on Alexandria Equities stock, see the ARE Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025